WAT Medical this week won FDA clearance for over-the-counter use of its HeadaTerm 2 wearable anti-migraine device.

HeadaTerm 2 uses neuromodulation technology. It releases targeted electrical impulses that increase the pain tolerance of the wearer. It is FDA-cleared for the preventative treatment of migraine headaches and is available without a prescription in the U.S.

HeadaTerm2 doesn’t use an app and allows all controls to be managed with one button for ease of operation. The approach simplifies the user experience and eliminates the need for complex installations or additional software.